Consolidated Condensed Balance Sheets (USD $)
In Millions, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Current Assets    
Cash and cash equivalents $ 3,064.8 $ 3,871.6
Short-term investments 1,075.0 955.4
Accounts receivable, net of allowances of $49.9 (2015) and $55.0 (2014) 3,142.5 3,234.6
Other receivables 683.2 566.7
Inventories 2,980.2 2,740.0
Prepaid expenses and other 797.0 811.5
Total current assets 11,742.7 12,179.8
Other Assets    
Restricted cash 0 5,405.6
Investments 4,576.5 4,568.9
Goodwill 3,946.9 1,758.1
Other intangibles, net 4,947.7 2,884.2
Sundry 2,489.4 2,417.7
Total other assets 15,960.5 17,034.5
Property and Equipment    
Land, buildings, equipment, and construction in progress 16,213.3 16,029.3
Accumulated depreciation (8,262.6) (8,065.4)
Property and equipment, net 7,950.7 7,963.9
Total assets 35,653.9 37,178.2
Current Liabilities    
Short-term borrowings and current maturities of long-term debt 805.4 2,688.7
Accounts payable 1,179.6 1,128.1
Employee compensation 518.7 759.0
Sales rebates and discounts 2,025.7 2,068.8
Dividends payable 0 530.3
Deferred income taxes 1,296.7 1,466.5
Other current liabilities 2,516.8 2,566.1
Total current liabilities 8,342.9 11,207.5
Other Liabilities    
Long-term debt 7,415.3 5,367.7
Accrued retirement benefits 2,520.8 2,562.9
Long-term income taxes payable 954.0 998.5
Other noncurrent liabilities 1,474.4 1,653.5
Total other liabilities 12,364.5 10,582.6
Eli Lilly and Company Shareholders' Equity    
Common stock 694.1 694.6
Additional paid-in capital 5,279.6 5,292.3
Retained earnings 16,706.8 16,482.7
Employee benefit trust (3,013.2) (3,013.2)
Accumulated other comprehensive loss (4,657.5) (3,991.8)
Cost of common stock in treasury (90.0) (91.4)
Total Eli Lilly and Company shareholders' equity 14,919.8 15,373.2
Noncontrolling interests 26.7 14.9
Total equity 14,946.5 15,388.1
Total liabilities and equity $ 35,653.9 $ 37,178.2